Sfoglia per AUTORE
CAPOBIANCO M
Collezione AOU San Luigi di Orbassano

  

Items : 90

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2024 Jan;11(1):e200188. doi: 10.1212/NXI.0000000000200188. Epub 20
2024
AOU San Luigi di Orbassano

Carta S; Dinoto A; Capobianco M; Valentino P; Montarolo F; Sala A; Reindl M; Lo Re M; Chiodega V; Branger P; Audoin B; Aboab J; Papeix C; Collongues N; Kerschen P; Zephir H; Créange A; Bourre B; Schanda K; Flanagan EP; Redenbaugh V; Villacieros-Álvarez J; Arrambide G; Cobo-Calvo A; Ferrari S; Marignier R; Mariotto S; Carta S; Dinoto A; et alii...

COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients. in Journal of neurology / J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20.
2024
AOU San Luigi di Orbassano

Mascolo A; Copetti M; Trojano M; Patti F; Mirabella M; Marfia GA; Lus G; Granella F; Filippi M; De Luca G; Capobianco M; Matrone F; Bisecco A; Tedeschi G; Gallo A;

Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab. in Journal of neuroimmunology / J Neuroimmunol. 2023 Sep 15;382:578170. doi: 10.1016/j.jneuroim.2023.578170. Epub 2023 Aug 7.
2023
AOU San Luigi di Orbassano

Sottini A; Quaresima V; Barbaro M; Moiola L; Filippi M; Malentacchi M; Capobianco M; Puthenparampil M; Gallo P; Cocco E; Frau J; Zaffaroni M; Guaschino C; Stampatori C; Mancinelli C; Brambilla L; Clerici VT; Vianello M; Vitetta F; Ferraro D; Rosettani P; Danni MC; Conti M; Grimoldi M; Capra R; Imberti L;

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Sep;77:104893. doi: 10.1016/j.msard.2023.104893. Epub 2023 Jul 16.
2023
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Bava CI; Martire S; Capobianco M; Malentacchi M; Sperli F; Oggero A; Di Sapio A; Bertolotto A;

Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants. in Neurology / Neurology. 2023 Aug 29;101(9):e892-e903. doi: 10.1212/WNL.0000000000207534. Epub 2023 Jul 6.
2023
AOU San Luigi di Orbassano

Beretta S; Cristillo V; Camera G; Morotti Colleoni C; Pellitteri G; Viti B; Bianchi E; Gipponi S; Grimoldi M; Valente M; Guttmann S; Cotelli MS; Palumbo P; Gelosa G; Meletti S; Schenone C; Ottaviani D; Filippi M; Zini A; Basilico P; Tancredi L; Cortelli P; Braga M; De Giuli V; Servidei S; Paolicelli D; Verde F; Caproni S; Pisani A; et alii...

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Capobianco MA; Pautasso M; Bertolotto A; Valentino P; Martire S; Sala A; Sperli F; Malentacchi M; Malucchi S; Bruschi N;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

NURR1-deficient mice have age- and sex-specific behavioral phenotypes. in Journal of neuroscience research / J Neurosci Res. 2022 Sep;100(9):1747-1754. doi: 10.1002/jnr.25067. Epub 2022 May 20.
2022
AOU San Luigi di Orbassano

Montarolo F; Martire S; Chiara F; Allegra S; De Francia S; Hoxha E; Tempia F; Capobianco MA; Bertolotto A;

Fetal and post-natal growth in infants of mothers with multiple sclerosis: A case-control stud. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Sep;65:104087. doi: 10.1016/j.msard.2022.104087. Epub 2022 Aug 1.
2022
AOU San Luigi di Orbassano

Marozio L; Cavalla P; Sottemano S; Vercellino M; Federici F; Cosma S; Peila C; Cresi F; Coscia A; Capobianco M; Bosa C; Schillaci V; Bellisario V; Migliaretti G; Benedetto C;

sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Nov;67:104176. doi: 10.1016/j.msard.2022.104176. Epub 2022 Sep 14.
2022
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Martire S; Bava CI; Capobianco MA; Bertolotto A;

The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line. in Current issues in molecular biology / Curr Issues Mol Biol. 2022 Mar 7;44(3):1247-1256. doi: 10.3390/cimb44030083.
2022
AOU San Luigi di Orbassano

Montarolo F; Martire S; Marnetto F; Valentino P; Valverde S; Capobianco MA; Bertolotto A;

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration. in Journal of neurology / J Neurol. 2022 Mar;269(3):1463-1469. doi: 10.1007/s00415-021-10708-1. Epub 2021 Jul 22.
2022
AOU San Luigi di Orbassano

Vitetta F; Pisano E; Malucchi S; Cavalla P; Cellerino M; Patti F; Lus G; Mirabella M; Zaffaroni M; Brescia Morra V; Capobianco M; Inglese M; Guerra T; Iaffaldano P; Ferraro D; Paolicelli D; Sola P; Trojano M;

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes. in Molecular biology reports / Mol Biol Rep. 2022 Jun;49(6):4709-4718. doi: 10.1007/s11033-022-07320-5. Epub 2022 Mar 12.
2022
AOU San Luigi di Orbassano

Martire S; Valentino P; Marnetto F; Mirabile L; Capobianco M; Bertolotto A;

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Jul;63:103909. doi: 10.1016/j.msard.2022.103909. Epub 2022 May 25.
2022
AOU San Luigi di Orbassano

Ponzano M; Schiavetti I; Bovis F; Landi D; Carmisciano L; De Rossi N; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Bragadin MM; Cocco E; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Bergamaschi R; Inglese M; Petracca M; Trojano M; Tedeschi G; Comi G; Battaglia MA; Patti F; Fragoso YD; Sen S; Siva A; et alii...

Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. in Journal of neuroinflammation / J Neuroinflammation. 2022 Jan 20;19(1):19. doi: 10.1186/s12974-021-02339-0.
2022
AOU San Luigi di Orbassano

Jarius S; Pache F; Körtvelyessy P; Jel?i? I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; et alii...

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 20
2022
AOU San Luigi di Orbassano

Sormani MP; Schiavetti I; Carmisciano L; Cordioli C; Filippi M; Radaelli M; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Cocco E; Scandellari C; Cavalla P; Pesci I; Zito A; Confalonieri P; Marfia GA; Perini P; Inglese M; Trojano M; Brescia Morra V; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; Schiavetti I; Carmisciano L; et alii...

A real-world study of alemtuzumab in a cohort of Italian patients. in European journal of neurology / Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5.
2022
AOU San Luigi di Orbassano

Russo CV; Saccà F; Frau J; Annovazzi P; Signoriello E; Bonavita S; Grasso R; Clerico M; Cordioli C; Laroni A; Capobianco M; Torri Clerici V; Sartori A; Cavalla P; Maniscalco GT; La Gioia S; Caleri F; Giugno A; Iodice R; Carotenuto A; Cocco E; Fenu G; Zaffaroni M; Baroncini D; Lus G; Gallo A; De Mercanti SF; Lapucci C; Di Francescantonio V; et alii...

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Feb;29(2):535-542. doi: 10.1111/ene.15167. Epub 2021 Nov 15.
2022
AOU San Luigi di Orbassano

Tedeschi G; Pisoni E; Brescia Morra V; Trojano M; Inglese M; Perini P; Marfia GA; Confalonieri P; Zito A; Cavalla P; Pesci I; Scandellari C; Cocco E; Brichetto G; De Rossi N; Capobianco M; Immovilli P; Radaelli M; Filippi M; Carmisciano L; Cordioli C; Schiavetti I; Ponzano M; Bergamaschi R; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; et alii...

Signs and symptoms of COVID-19 in patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23.
2022
AOU San Luigi di Orbassano

Schiavetti I; Carmisciano L; Ponzano M; Cordioli C; Cocco E; Marfia GA; Inglese M; Filippi M; Radaelli M; Bergamaschi R; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Trojano M; Lanzillo R; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP;

Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors. in Journal of neurology / J Neurol. 2022 Apr;269(4):1817-1824. doi: 10.1007/s00415-021-10782-5. Epub 2021 Sep 27.
2022
AOU San Luigi di Orbassano

Puthenparampil M; Perini P; Bergamaschi R; Capobianco M; Filippi M; Gallo P; Puthenparampil M; Perini P; Bergamaschi R; Capobianco M; Filippi M; Gallo P;

Myelin-oligodendrocyte glycoprotein antibody-associated disease. in The Lancet. Neurology / Lancet Neurol. 2021 Sep;20(9):762-772. doi: 10.1016/S1474-4422(21)00218-0.
2021
AOU San Luigi di Orbassano

Marignier R; Hacohen Y; Cobo-Calvo A; Pröbstel AK; Aktas O; Alexopoulos H; Amato MP; Asgari N; Banwell B; Bennett J; Brilot F; Capobianco M; Chitnis T; Ciccarelli O; Deiva K; De Sèze J; Fujihara K; Jacob A; Kim HJ; Kleiter I; Lassmann H; Leite MI; Linington C; Meinl E; Palace J; Paul F; Petzold A; Pittock S; Reindl M; et alii...

Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2021 May;42(Suppl 1):25-28. doi: 10.1007/s10072-020-05027-8. Epub 2021 Mar 12.
2021
AOU San Luigi di Orbassano

Capobianco M; Bertolotto A; Malucchi S;

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2021 Mar;27(3):347-359. doi: 10.1177/1352458520952310. Epub 2020 Sep 17.
2021
AOU San Luigi di Orbassano

Scarpazza C; Puoti M; Prosperini L; Origoni M; Meroni L; Gerevini S; Galli M; Franzetti F; Comi G; Fasolo MM; Cinque P; Capra R; Capobianco M; Benatti SV; Barcella V; Riva A; Tortorella C; Zaffaroni M; Moiola L;

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2021 Mar;27(3):331-346. doi: 10.1177/1352458520952311. Epub 2020 Sep 17.
2021
AOU San Luigi di Orbassano

Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; Gerevini S; Meroni L; Origoni M; Prosperini L; Puoti M; Scarpazza C; Tortorella C; Zaffaroni M; Riva A; Moiola L; Barcella V; Benatti S; Capobianco M; Capra R; Cinque P; Comi G; Fasolo MM; Franzetti F; Galli M; et alii...

Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. in Neurology / Neurology. 2021 Feb 22;96(8):e1215-e1226. doi: 10.1212/WNL.0000000000011461.
2021
AOU San Luigi di Orbassano

Boffa G; Massacesi L; Inglese M; Mariottini A; Capobianco M; Moiola L; Amato MP; Cottone S; Gualandi F; De Gobbi M; Greco R; Scimè R; Frau J; Zimatore GB; Bertolotto A; Comi G; Uccelli A; Signori A; Angelucci E; Innocenti C; Ciceri F; Repice AM; Sormani MP; Saccardi R; Mancardi G;

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study. in Journal of neurology / J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano

Bucello S; Annovazzi P; Ragonese P; Altieri M; Barcella V; Bergamaschi R; Bianchi A; Borriello G; Buscarinu MC; Callari G; Capobianco M; Capone F; Cavalla P; Cavarretta R; Cortese A; De Luca G; Di Filippo M; Dattola V; Fantozzi R; Ferraro E; Filippi MM; Gasperini C; Grimaldi LME; Landi D; Re ML; Mallucci G; Manganotti P; Marfia GA; Mirabella M; et alii...

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano

Sormani MP; Salvetti M; Labauge P; Schiavetti I; Zephir H; Carmisciano L; Bensa C; De Rossi N; Pelletier J; Cordioli C; Vukusic S; Moiola L; Kerschen P; Radaelli M; Théaudin M; Immovilli P; Casez O; Capobianco M; Ciron J; Trojano M; Stankoff B; Créange A; Tedeschi G; Clavelou P; Comi G; Thouvenot E; Battaglia MA; Moreau T; Patti F; et alii...

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. in Annals of neurology / Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9.
2021
AOU San Luigi di Orbassano

Sormani MP; De Rossi N; Schiavetti I; Carmisciano L; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Trojano M; Zaratin P; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M;

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. in Therapeutic advances in neurological disorders / Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollectio
2021
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Caputo F; Paolicelli D; Patti F; Zaffaroni M; Brescia Morra V; Pozzilli C; De Luca G; Inglese M; Salemi G; Maniscalco GT; Cocco E; Sola P; Lus G; Conte A; Amato MP; Granella F; Gasperini C; Bellantonio P; Totaro R; Rovaris M; Salvetti M; Torri Clerici VLA; Bergamaschi R; Maimone D; Scarpini E; Capobianco M; Comi G; et alii...

Concomitant brain arterial and venous thrombosis in a COVID-19 patient. in European journal of neurology / Eur J Neurol. 2020 Sep;27(9):e38-e39. doi: 10.1111/ene.14380. Epub 2020 Jun 30.
2020
AOU San Luigi di Orbassano

Malentacchi M; Gned D; Angelino V; Demichelis S; Perboni A; Veltri A; Bertolotto A; Capobianco M;

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Sep;44:102251. doi: 10.1016/j.msard.2020.102251. Epub 2020 Jun 2.
2020
AOU San Luigi di Orbassano

Whittam DH; Cobo-Calvo A; Lopez-Chiriboga AS; Pardo S; Gornall M; Cicconi S; Brandt A; Berek K; Berger T; Jelcic I; Gombolay G; Oliveira LM; Callegaro D; Kaneko K; Misu T; Capobianco M; Gibbons E; Karthikeayan V; Brochet B; Audoin B; Mathey G; Laplaud D; Thouvenot E; Cohen M; Tourbah A; Maillart E; Ciron J; Deschamps R; Biotti D; et alii...

Treatment and outcome of aquaporin-4 antibody-positive NMOSD: A multinational pediatric study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2020 Jul 30;7(5):e837. doi: 10.1212/NXI.0000000000000837. Print 20
2020
AOU San Luigi di Orbassano

Paolilo RB; Hacohen Y; Yazbeck E; Armangue T; Bruijstens A; Lechner C; Apostolos-Pereira SL; Martynenko Y; Breu M; de Medeiros Rimkus C; Wassmer E; Baumann M; Papetti L; Capobianco M; Kornek B; Rostásy K; da Paz JA; Ciccarelli O; Lim M; Saiz A; Neuteboom R; Marignier R; Hemingway C; Sato DK; Deiva K;

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Oct;41(10):2843-2851. doi: 10.1007/s10072-020-04380-y. Epub 2020 Apr 21.
2020
AOU San Luigi di Orbassano

Comi G; Pozzilli C; Morra VB; Bertolotto A; Sangalli F; Prosperini L; Carotenuto A; Iaffaldano P; Capobianco M; Colombo D; Nica M; Rizzoli S; Trojano M;

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano

Gobbi C; Uccelli A; Signori A; Amato MP; Granella F; Barilaro A; Abbadessa G; Fenu G; Brescia Morra V; Prestipino E; Sperli F; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Gallo A; Sacco R; Mechi C; Salemi G; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Barone S; Maniscalco GT; Di Sapio A; et alii...

E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. in European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society / Eur J Paediatr Neurol. 2020 Nov;29:41-53. doi: 10.1016/j.ejpn.2020.10.005. Epub 2020 Nov 4.
2020
AOU San Luigi di Orbassano

Bruijstens AL; Wendel EM; Lechner C; Bartels F; Finke C; Breu M; Flet-Berliac L; de Chalus A; Adamsbaum C; Capobianco M; Laetitia G; Hacohen Y; Hemingway C; Wassmer E; Lim M; Baumann M; Wickström R; Armangue T; Rostasy K; Deiva K; Neuteboom RF;

E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. in European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society / Eur J Paediatr Neurol. 2020 Nov;29:22-31. doi: 10.1016/j.ejpn.2020.11.001. Epub 2020 Nov 7.
2020
AOU San Luigi di Orbassano

Armangue T; Capobianco M; de Chalus A; Laetitia G; Deiva K;

Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis. in Dermatologic therapy / Dermatol Ther. 2020 Nov;33(6):e13943. doi: 10.1111/dth.13943. Epub 2020 Jul 14.
2020
AOU San Luigi di Orbassano

Di Tullio F; Odorici G; Lasagni C; Capobianco M; Conti A; Mandel VD;

Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.
2020
AOU San Luigi di Orbassano

Masuccio FG; Lo Re M; Bertolotto A; Capobianco M; Solaro C;

Treatment of MOG antibody associated disorders: results of an international survey. in Journal of neurology / J Neurol. 2020 Dec;267(12):3565-3577. doi: 10.1007/s00415-020-10026-y. Epub 2020 Jul 4.
2020
AOU San Luigi di Orbassano

Whittam DH; Karthikeayan V; Gibbons E; Kneen R; Chandratre S; Ciccarelli O; Hacohen Y; de Seze J; Deiva K; Hintzen RQ; Wildemann B; Jarius S; Kleiter I; Rostasy K; Huppke P; Hemmer B; Paul F; Aktas O; Pröbstel AK; Arrambide G; Tintore M; Amato MP; Nosadini M; Mancardi MM; Capobianco M; Illes Z; Siva A; Altintas A; Akman-Demir G; et alii...

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients. in Neurology and therapy / Neurol Ther. 2020 Dec;9(2):197-203. doi: 10.1007/s40120-020-00200-9. Epub 2020 Jun 16.
2020
AOU San Luigi di Orbassano

Bertolotto A; Martire S; Mirabile L; Capobianco M; De Gobbi M; Cilloni D;

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study. in Journal of neurology / J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17.
2019
AOU San Luigi di Orbassano

Frau J; Saccà F; Signori A; Baroncini D; Fenu G; Annovazzi P; Capobianco M; Signoriello E; Laroni A; La Gioia S; Sartori A; Maniscalco GT; Bonavita S; Clerico M; Russo CV; Gallo A; Lapucci C; Carotenuto A; Sormani MP; Cocco E;

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4.
2019
AOU San Luigi di Orbassano

Novi G; Bovis F; Capobianco M; Frau J; Mataluni G; Curti E; Zuliani L; Cavalla P; Brambilla L; Annovazzi P; Repice AM; Lanzillo R; Esposito S; Benedetti L; Maietta I; Sica F; Buttari F; Malucchi S; Fenu G; Landi D; Bosa C; Realmuto S; Malentacchi M; Granella F; Signori A; Bonavita S; Uccelli A; Sormani MP;

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24.
2019
AOU San Luigi di Orbassano

Baroncini D; Zaffaroni M; Moiola L; Lorefice L; Fenu G; Iaffaldano P; Simone M; Fanelli F; Patti F; D'Amico E; Capobianco M; Bertolotto A; Gallo P; Margoni M; Miante S; Milani N; Amato MP; Righini I; Bellantonio P; Scandellari C; Costantino G; Scarpini E; Bergamaschi R; Mallucci G; Comi G; Ghezzi A;

2019
AOU San Luigi di Orbassano

Paolicelli D; Lucisano G; Manni A; Avolio C; Bonavita S; Brescia Morra V; Capobianco M; Cocco E; Conte A; De Luca G; De Robertis F; Gasperini C; Gatto M; Gazzola P; Lus G; Iaffaldano A; Iaffaldano P; Maimone D; Mallucci G; Maniscalco GT; Marfia GA; Patti F; Pesci I; Pozzilli C; Rovaris M; Salemi G; Salvetti M; Spitaleri D; Totaro R; et alii...

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2018 Sep 13;5(6):e498. doi: 10.1212/NXI.0000000000000498. eCollect
2018
AOU San Luigi di Orbassano

Marcinnò A; Marnetto F; Valentino P; Martire S; Balbo A; Drago A; Leto M; Capobianco M; Panzica G; Bertolotto A;

Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]. in Journal of the neurological sciences / J Neurol Sci. 2017 Sep 15;380:19. doi: 10.1016/j.jns.2017.06.037. Epub 2017 Jul 4.
2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Dec 15;4(2):e317. doi: 10.1212/NXI.0000000000000317. eCollect
2017
AOU San Luigi di Orbassano

Valentino P; Marnetto F; Granieri L; Capobianco M; Bertolotto A;

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.
2017
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;

Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? in Journal of the neurological sciences / J Neurol Sci. 2017 Jul 15;378:233-237. doi: 10.1016/j.jns.2017.05.018. Epub 2017 May 12.
2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;

2016
AOU San Luigi di Orbassano

Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; et alii...

2016
AOU San Luigi di Orbassano

Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; et alii...

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. in Journal of neurology / J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.
2016
AOU San Luigi di Orbassano

Moiola L; Annovazzi P; Capobianco M; Patti F; Frau J; Uccelli A; Centonze D; Perini P; Tortorella C; Prosperini L; Lus G; Fuiani A; Falcini M; Martinelli V; Comi G; Ghezzi A;

The Case | The young philosopher with multiple sclerosis and proteinuria. in Kidney international / Kidney Int. 2016 Apr;89(4):961-3. doi: 10.1016/j.kint.2015.10.013.
2016
AOU San Luigi di Orbassano

Piccoli GB; Capobianco M; Vigotti FN; Naretto C; Narioz C; Brocheriou I; Roccatello D;

Anal sphincter dysfunction in multiple sclerosis: an observation manometric study. in Open medicine (Warsaw, Poland) / Open Med (Wars). 2016 Nov 25;11(1):509-517. doi: 10.1515/med-2016-0088. eCollection 2016.
2016
AOU San Luigi di Orbassano

Marola S; Ferrarese A; Gibin E; Capobianco M; Bertolotto A; Enrico S; Solej M; Martino V; Destefano I; Nano M;

2016
AOU San Luigi di Orbassano

Troni W; Melillo F; Bertolotto A; Malucchi S; Capobianco M; Sperli F; Di Sapio A;

2015
AOU San Luigi di Orbassano

Capobianco M; di Sapio A; Malentacchi M; Malucchi S; Matta M; Sperli F; Bertolotto A;

Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-? Therapy. in Neurology and therapy / Neurol Ther. 2015 Jun;4(1):53-60. doi: 10.1007/s40120-015-0027-z. Epub 2015 Mar 6.
2015
AOU San Luigi di Orbassano

Motuzova Y; Di Sapio A; Capobianco M; Sala A; Marnetto F; Malucchi S; Bertolotto A;

Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers. in Neurology and therapy / Neurol Ther. 2015 Dec;4(2):147-57. doi: 10.1007/s40120-015-0038-9. Epub 2015 Dec 8.
2015
AOU San Luigi di Orbassano

Lo Re M; Capobianco M; Ragonese P; Realmuto S; Malucchi S; Berchialla P; Salemi G; Bertolotto A;

Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec
2015
AOU San Luigi di Orbassano

Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. in PloS one / PLoS One. 2015 Jun 5;10(6):e0129291. doi: 10.1371/journal.pone.0129291. eCollection 2015.
2015
AOU San Luigi di Orbassano

Perga S; Giuliano Albo A; Lis K; Minari N; Falvo S; Marnetto F; Caldano M; Reviglione R; Berchialla P; Capobianco MA; Malentacchi M; Corpillo D; Bertolotto A;

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.
2014
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Trojano M; Zaffaroni M; Malucchi S; Bertolotto A; Capobianco M; et alii...

CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study. in Journal of neuroimmunology / J Neuroimmunol. 2014 Dec 15;277(1-2):127-33. doi: 10.1016/j.jneuroim.2014.09.008. Epub 2014 Sep 20.
2014
AOU San Luigi di Orbassano

Marnetto F; Granieri L; Valentino P; Capobianco M; Pautasso M; Bertolotto A;

Identifying responders and nonresponders to interferon therapy in multiple sclerosis. in Degenerative neurological and neuromuscular disease / Degener Neurol Neuromuscul Dis. 2014 Apr 1;4:75-85. doi: 10.2147/DNND.S42734. eCollection 2014.
2014
AOU San Luigi di Orbassano

Prosperini L; Capobianco M; Giannì C;

Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2012 Aug;33(4):863-7. doi: 10.1007/s10072-011-0848-1. Epub 2011 Nov 25.
2012
AOU San Luigi di Orbassano

Capobianco M; Motuzova Y; Frau J; Cocco E; Mamusa E; Marrosu MG; Bertolotto A;

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology. in PloS one / PLoS One. 2012;7(6):e38896. doi: 10.1371/journal.pone.0038896. Epub 2012 Jun 12.
2012
AOU San Luigi di Orbassano

Granieri L; Marnetto F; Valentino P; Frau J; Patanella AK; Nytrova P; Sola P; Capobianco M; Jarius S; Bertolotto A;

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.
2011
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.
2011
AOU San Luigi di Orbassano

Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;

Acute renal failure, severe sodium and potassium imbalance and sudden tetraplegia. in NDT plus / NDT Plus. 2010 Jun;3(3):247-252. doi: 10.1093/ndtplus/sfq017. Epub 2010 Mar 19.
2010
AOU San Luigi di Orbassano

Piccoli GB; Capobianco M; Odetto L; Deagostini MC; Consiglio V; Radeschi G;

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.
2010
AOU San Luigi di Orbassano

Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;

Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica. in Journal of neuroimmunology / J Neuroimmunol. 2009 Dec 10;217(1-2):74-9. doi: 10.1016/j.jneuroim.2009.10.002. Epub 2009 Oct 21.
2009
AOU San Luigi di Orbassano

Marnetto F; Hellias B; Granieri L; Frau J; Patanella AK; Nytrova P; Sala A; Capobianco M; Gilli F; Bertolotto A;

Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S227-9. doi: 10.1007/s10072-008-0945-y.
2008
AOU San Luigi di Orbassano

Capobianco M; Rizzo A; Malucchi S; Sperli F; Di Sapio A; Oggero A; Zaffaroni M; Ghezzi A; Bertolotto A;

Predictive markers for response to interferon therapy in patients with multiple sclerosis. in Neurology / Neurology. 2008 Mar 25;70(13 Pt 2):1119-27. doi: 10.1212/01.wnl.0000304040.29080.7b. Epub 2008 Feb 1
2008
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A;

Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Jun;29(3):185-7. doi: 10.1007/s10072-008-0934-1. Epub 2008 Jul 9.
2008
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A;

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis. in Neurology / Neurology. 2008 Dec 9;71(24):1940-7. doi: 10.1212/01.wnl.0000327340.50284.8d. Epub 2008 Oct 29.
2008
AOU San Luigi di Orbassano

Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A;

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.
2007
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2007 Aug;28(4):209-11. doi: 10.1007/s10072-007-0823-z. Epub 2007 Aug 10.
2007
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A;

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. in Journal of immunological methods / J Immunol Methods. 2007 Apr 10;321(1-2):19-31. doi: 10.1016/j.jim.2006.12.012. Epub 2007 Feb 20.
2007
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F;

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.
2006
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.
2005
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2005 Dec;26 Suppl 4:S213-4. doi: 10.1007/s10072-005-0517-3.
2005
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Gilli F; Marnetto F; Caldano M; Sala A; Bertolotto A;

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.
2004
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. in Neurology / Neurology. 2004 Jun 8;62(11):2031-7. doi: 10.1212/01.wnl.0000129265.73259.9e.
2004
AOU San Luigi di Orbassano

Malucchi S; Sala A; Gilli F; Bottero R; Di Sapio A; Capobianco M; Bertolotto A;

Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology / Mol Diagn. 2004;8(3):185-94. doi: 10.1007/BF03260063.
2004
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Stefanuto G; Rinaldi V; Farinazzo F; Malucchi S; Capobianco M; Caldano M; Sala A; Bertolotto A;

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y.
2003
AOU San Luigi di Orbassano

Milano E; Di Sapio A; Malucchi S; Capobianco M; Bottero R; Sala A; Gilli F; Bertolotto A;

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. in Neurology / Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5.
2003
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Capobianco M; Malucchi S; Milano E; Melis F; Marnetto F; Lindberg RL; Bottero R; Di Sapio A; Giordana MT;

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):148-53. doi: 10.1136/jnnp.73.2.148.
2002
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Sala A; Orefice G; Carrieri PB; Capobianco M; Milano E; Melis F; Giordana MT;

Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations. in Immunopharmacology / Immunopharmacology. 2000 Jul 20;48(2):95-100. doi: 10.1016/s0162-3109(00)00182-x.
2000
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Milano E; Castello A; Capobianco M; Mutani R;

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. in Neuroscience letters / Neurosci Lett. 1999 Mar 19;263(1):21-4. doi: 10.1016/s0304-3940(99)00102-0.
1999
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Malucchi S; Manzardo E; Audano L; Bergui M; Bradac GB; Mutani R;

Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research / J Interferon Cytokine Res. 1999 Jun;19(6):575-81. doi: 10.1089/107999099313703.
1999
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Capobianco M; Manzardo E; Guastamacchia G; Milano E; Audano L; Mutani R;